BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9000140)

  • 21. E1A second exon requirements for induction of target cell susceptibility to lysis by natural killer cells: implications for the mechanism of action.
    Krantz CK; Routes BA; Quinlan MP; Cook JL
    Virology; 1996 Mar; 217(1):23-32. PubMed ID: 8599207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus E1A requires c-Ras for full neoplastic transformation or suppression of differentiation of murine preadipocytes.
    Cao J; Arulanandam R; Vultur A; Anagnostopoulou A; Raptis L
    Mol Carcinog; 2007 Apr; 46(4):284-302. PubMed ID: 17295229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cells.
    Rumpf H; Esche H; Kirch HC
    Virology; 1999 Apr; 257(1):45-53. PubMed ID: 10208919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recruitment of TRRAP required for oncogenic transformation by E1A.
    Deleu L; Shellard S; Alevizopoulos K; Amati B; Land H
    Oncogene; 2001 Dec; 20(57):8270-5. PubMed ID: 11781841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential transformation of primary human embryo retinal cells by adenovirus E1 regions and combinations of E1A + ras.
    Byrd PJ; Grand RJ; Gallimore PH
    Oncogene; 1988 May; 2(5):477-84. PubMed ID: 2967455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the pRb-binding regions of E1A enables efficient transformation of primary epithelial cells by v-src.
    Fischer RS; Quinlan MP
    J Virol; 1998 Apr; 72(4):2815-24. PubMed ID: 9525601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
    Nevels M; Spruss T; Wolf H; Dobner T
    Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7.
    Parker GA; Crook T; Bain M; Sara EA; Farrell PJ; Allday MJ
    Oncogene; 1996 Dec; 13(12):2541-9. PubMed ID: 9000128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein.
    Subramanian T; La Regina M; Chinnadurai G
    Oncogene; 1989 Apr; 4(4):415-20. PubMed ID: 2524023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells.
    Routes JM
    J Immunol; 1993 May; 150(10):4315-22. PubMed ID: 7683316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rat embryo fibroblasts transformed by complementation with oncogenes E1A+E1B-19 and E1A+cHa-ras differ in the ability to realize the G1/S block in serum free media].
    Brichkina AI; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Tsitologiia; 2001; 43(11):1024-30. PubMed ID: 11840777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes.
    Gallimore PH; Grand RJ; Byrd PJ
    Anticancer Res; 1986; 6(3 Pt B):499-508. PubMed ID: 3017183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 12S adenoviral E1A protein immortalizes avian cells and interacts with the avian RB product.
    Guilhot C; Benchaibi M; Flechon JE; Samarut J
    Oncogene; 1993 Mar; 8(3):619-24. PubMed ID: 8437845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E1A oncogene expression level in sarcoma cells: an independent determinant of cytolytic susceptibility and tumor rejection.
    Cook JL; Wilson BA; Wolf LA; Walker TA
    Oncogene; 1993 Mar; 8(3):625-35. PubMed ID: 8437846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus E1A-p105(Rb) protein interactions play a direct role in the initiation but not the maintenance of the rodent cell transformed phenotype.
    Nielsch U; Fognani C; Babiss LE
    Oncogene; 1991 Jun; 6(6):1031-6. PubMed ID: 2067843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of major histocompatibility complex class I expression and susceptibility to natural killer cells in cells transformed with the oncogenic adenovirus 12 are regulated by different E1A domains.
    Huvent I; Cousin C; Kiss A; Baroni de Moraes MT; Bernard C; D'Halluin JC
    Cancer Detect Prev; 1997; 21(1):12-21. PubMed ID: 9043758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell type dependent transformation by adenovirus 5 E1a proteins.
    Kuppuswamy M; Chinnadurai G
    Oncogene; 1988 Jun; 2(6):567-72. PubMed ID: 2968533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Constitutive activity of MAP kinase cascades in REF cells transformed by E1A and cHa-ras oncogenes].
    Svetlikova SB; Abramova MV; Kukushkin AN; Darieva ZA; Pospelova TV; Pospelov VA
    Tsitologiia; 2001; 43(10):961-8. PubMed ID: 11769129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immortalization by large T-antigen of the adult epididymal duct epithelium.
    Kirchhoff C; Araki Y; Huhtaniemi I; Matusik RJ; Osterhoff C; Poutanen M; Samalecos A; Sipilä P; Suzuki K; Orgebin-Crist MC
    Mol Cell Endocrinol; 2004 Mar; 216(1-2):83-94. PubMed ID: 15109748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.